ArticlePloS one2025
A quality improvement initiative to increase HIV post-exposure prophylaxis treatment for emergency department patients after sexual assault: A pre-post study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMany emergency department (ED) patients after a sexual assault face barriers to receiving HIV post-exposure prophylaxis (PEP). We implemented a quality improvement initiative which updated the sexual assault electronic health record (EHR) template and made available free, full-course PEP treatment packs for use at provider discretion. The aim of this study was to compare the receipt of HIV PEP for ED patients receiving sexual assault care before and after the initiative.
methodsThis was a retrospective, quasi-experimental, pre-post study of all ED patients who completed a sexual assault examination between June 1, 2022 - January 31, 2023 (pre-intervention) and March 1, 2023 - October 31, 2023 (post-intervention). An odds ratio (OR) and 95% confidence interval (CI) were calculated to determine the initiative's effect on PEP prescribing. Multivariable logistic regression models estimated the independent effect of the initiative while controlling for potential confounders.
resultsOf the 235 sexual assault examinations, 117 (49.8%) were during the pre-intervention and 118 (50.2%) were during the post-intervention periods. Pre-intervention, the mean age was 33.0 years (standard deviation [SD] 12.3), 94.0% were female, 30.8% Black, 31.6% Latinx, and 28.2% White. Post-intervention, the mean age was 29.2 years (SD 12.6), 90.7% were female, 42.4% Black, 28.8% Latinx, and 17.8% White. Patients were more likely to receive HIV PEP post-intervention (33/118, 28.0%) than pre-intervention (11/117, 9.4%) (OR 3.7, 95% CI 1.8 to 7.8). The independent effect of the initiative on HIV PEP prescribing remained significant after controlling for demographics (OR 3.6, 95% CI 1.6 to 8.0), assault characteristics (OR 4.2, 95% CI 1.6 to 11.1), and provider experience (OR 3.5, 95% CI 1.7 to 7.5).
conclusionThe availability of HIV PEP treatment packs plus a modification to the EHR template led to a significant increase in the provision of HIV PEP for ED patients after sexual assault.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.